{{Underlinked|date=May 2016}}
{{chembox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 444260398
| ImageFile=Fluindione.png
| ImageSize=220px
| ImageAlt = Structural formula of fluindione
| ImageFile1 = Fluindione 3D ball.png
| ImageSize1=220px
| ImageAlt1 = Ball-and-stick model of the fluindione molecule
| IUPACName=2-(4-fluorophenyl)indane-1,3-dione
| OtherNames=
|Section1={{Chembox Identifiers
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = EQ35YMS20Q
| CASNo_Ref = {{cascite|correct|??}}
| CASNo = 957-56-2 
| PubChem = 68942
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07969
| SMILES = C1=CC=C2C(=C1)C(=O)C(C2=O)C3=CC=C(C=C3)F
| EINECS = 213-484-5 
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 62167
| InChI = 1/C15H9FO2/c16-10-7-5-9(6-8-10)13-14(17)11-3-1-2-4-12(11)15(13)18/h1-8,13H
| InChIKey = NASXCEITKQITLD-UHFFFAOYAN
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C15H9FO2/c16-10-7-5-9(6-8-10)13-14(17)11-3-1-2-4-12(11)15(13)18/h1-8,13H
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = NASXCEITKQITLD-UHFFFAOYSA-N
| RTECS = 
| MeSHName = C017673
  }}
|Section2={{Chembox Properties
| C=15 | H=9 | F=1 | O=2
| Appearance=
| Density=
| MeltingPt=
| BoilingPt=
| Solubility=
  }}
|Section6={{Chembox Pharmacology
| ATCCode_prefix = B01
| ATCCode_suffix = AA12
}}
|Section7={{Chembox Hazards
| MainHazards=
| FlashPt=
| AutoignitionPt =
  }}
}}

'''Fluindione''' is a [[vitamin K antagonist]].<ref name="pmid9465843">{{cite journal |vauthors=Mentré F, Pousset F, Comets E |title=Population pharmacokinetic-pharmacodynamic analysis of fluindione in patients |journal=Clin. Pharmacol. Ther. |volume=63 |issue=1 |pages=64–78 |date=January 1998 |pmid=9465843 |doi=10.1016/S0009-9236(98)90122-9|display-authors=etal}}</ref>

==References==
{{reflist}}

[[Category:Fluoroarenes]]
[[Category:Indandiones]]


{{blood-drug-stub}}